iNPH—the mystery resolving
Idiopathic normal pressure hydrocephalus (iNPH) is characterized clinically by degradation of gait, cognition, and urinary continence. INPH is progressive (Andrén et al, 2014), still probably underdiagnosed (Williams et al, 2019) but potentially treatable by CSF diversion (Kazui et al, 2015). Famili...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | EMBO Molecular Medicine |
Online Access: | https://doi.org/10.15252/emmm.202013720 |
id |
doaj-0fe1b4fa1290471197a5c43e80a21c0f |
---|---|
record_format |
Article |
spelling |
doaj-0fe1b4fa1290471197a5c43e80a21c0f2021-08-02T15:28:21ZengWileyEMBO Molecular Medicine1757-46761757-46842021-03-01133n/an/a10.15252/emmm.202013720iNPH—the mystery resolvingVille Leinonen0Teemu Kuulasmaa1Mikko Hiltunen2Institute of Clinical Medicine Neurosurgery University of Eastern Finland Kuopio FinlandInstitute of Biomedicine University of Eastern Finland Kuopio FinlandInstitute of Biomedicine University of Eastern Finland Kuopio FinlandIdiopathic normal pressure hydrocephalus (iNPH) is characterized clinically by degradation of gait, cognition, and urinary continence. INPH is progressive (Andrén et al, 2014), still probably underdiagnosed (Williams et al, 2019) but potentially treatable by CSF diversion (Kazui et al, 2015). Familial aggregation is a strong indicator of genetic regulation in the disease process iNPH (Fig 1). Enlargement of brain ventricles is associated with failed cerebrospinal (CSF) homeostasis by so far mostly unknown mechanisms. A mutation of the cilia gene CFAP43 in iNPH family, confirmed by a knocked‐out mouse model (Morimoto et al, 2019), allelic variation of NME8 (Huovinen et al, 2017), a segmental copy number loss in SFMBT1 in selected iNPH patients (Sato et al, 2016), and current results by Yang et al (2021) indicate that cilia dysfunction is one of the key mechanisms behind iNPH.https://doi.org/10.15252/emmm.202013720 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ville Leinonen Teemu Kuulasmaa Mikko Hiltunen |
spellingShingle |
Ville Leinonen Teemu Kuulasmaa Mikko Hiltunen iNPH—the mystery resolving EMBO Molecular Medicine |
author_facet |
Ville Leinonen Teemu Kuulasmaa Mikko Hiltunen |
author_sort |
Ville Leinonen |
title |
iNPH—the mystery resolving |
title_short |
iNPH—the mystery resolving |
title_full |
iNPH—the mystery resolving |
title_fullStr |
iNPH—the mystery resolving |
title_full_unstemmed |
iNPH—the mystery resolving |
title_sort |
inph—the mystery resolving |
publisher |
Wiley |
series |
EMBO Molecular Medicine |
issn |
1757-4676 1757-4684 |
publishDate |
2021-03-01 |
description |
Idiopathic normal pressure hydrocephalus (iNPH) is characterized clinically by degradation of gait, cognition, and urinary continence. INPH is progressive (Andrén et al, 2014), still probably underdiagnosed (Williams et al, 2019) but potentially treatable by CSF diversion (Kazui et al, 2015). Familial aggregation is a strong indicator of genetic regulation in the disease process iNPH (Fig 1). Enlargement of brain ventricles is associated with failed cerebrospinal (CSF) homeostasis by so far mostly unknown mechanisms. A mutation of the cilia gene CFAP43 in iNPH family, confirmed by a knocked‐out mouse model (Morimoto et al, 2019), allelic variation of NME8 (Huovinen et al, 2017), a segmental copy number loss in SFMBT1 in selected iNPH patients (Sato et al, 2016), and current results by Yang et al (2021) indicate that cilia dysfunction is one of the key mechanisms behind iNPH. |
url |
https://doi.org/10.15252/emmm.202013720 |
work_keys_str_mv |
AT villeleinonen inphthemysteryresolving AT teemukuulasmaa inphthemysteryresolving AT mikkohiltunen inphthemysteryresolving |
_version_ |
1721230532164976640 |